Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCHWIND is a global leader in ophthalmic laser technology for refractive and therapeutic corneal surgery. Its AMARIS excimer laser family and ATOS femtosecond laser are widely used in clinics worldwide for vision correction procedures. The company’s products are recognized for their precision and innovation in treating vision defects and corneal diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCHWIND eye-tech-solutions.